Patients with HbA1c < 7 % ( 53.0 mmol/mol ) were discharged on their preadmission diabetes therapy , HbA1c between 7 and 9 % ( 53.0-74 .9 mmol/mol ) were discharged on a preadmission regimen plus glargine at 50 % of hospital daily dose , and HbA1c > 9 % were discharged on oral antidiabetes agents ( OADs ) plus glargine or basal bolus regimen at 80 % of inpatient dose .